Vimarsana
Biggest News Aggregation in the World

Page 34 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oint Inflammation Today - Breaking & Trending Today

FDA Approves Idacio as Eighth Adalimumab Biosimilar in US - Vimarsana News

FDA Approves Idacio as Eighth Adalimumab Biosimilar in US

Data for Idacio (adalimumab-aacf) showed safety, efficacy, and immunogenicity similar to Humira.

RA Risk Raised by Work-Related Inhaled Agents - Vimarsana News

RA Risk Raised by Work-Related Inhaled Agents

Exposure to detergents, dusts, and other chemicals in the workplace could be putting genetically susceptible people at risk of rheumatoid arthritis.

DMARDs for RA Improve Vascular Inflammation and CV Risk - Vimarsana News

DMARDs for RA Improve Vascular Inflammation and CV Risk

Receipt of a tumor necrosis factor inhibitor or triple therapy for rheumatoid arthritis yielded an equally beneficial effect for reducing vascular inflammation and cardiovascular risk.

Anti-inflammatory pain relievers may worsen inflammation in osteoarthritis - Vimarsana News

Anti-inflammatory pain relievers may worsen inflammation in osteoarthritis

Taking anti-inflammatory pain relievers like ibuprofen and naproxen for osteoarthritis may worsen inflammation in the knee joint over time, according to a new study being presented next week at the annual meeting of the Radiological Society of North America.

Opioids Increase Risk for All-Cause Deaths in RA vs. NSAIDs - Vimarsana News

Opioids Increase Risk for All-Cause Deaths in RA vs. NSAIDs

The incidence of all-cause mortality was higher for patients with rheumatoid arthritis who started on opioids rather than NSAIDs for pain control.